| USBLX | VTMFX | USBLX / VTMFX | |
| Total Expense Ratio | 0.52 | 0.05 | 1,040% |
| Annual Report Gross Expense Ratio | 0.52 | 0.05 | 1,040% |
| Fund Existence | 38 years | 32 years | - |
| Gain YTD | 4.712 | 3.332 | 141% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 3000 | 10000 | 30% |
| Min. Initial Investment IRA | 3000 | N/A | - |
| Net Assets | 914M | 12.3B | 7% |
| Annual Yield % from dividends | 2.24 | 2.19 | 102% |
| Returns for 1 year | 7.48 | 5.08 | 147% |
| Returns for 3 years | 39.43 | 32.14 | 123% |
| Returns for 5 years | 32.49 | 27.51 | 118% |
| Returns for 10 years | 101.68 | 94.10 | 108% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MXVIX | 48.97 | N/A | N/A |
| Empower S&P 500® Index Investor | |||
| GGESX | 27.08 | N/A | N/A |
| Nationwide Schroders Global Eq Instl Svc | |||
| TISVX | 19.69 | N/A | N/A |
| Transamerica International Sm Cp Val I | |||
| FIJYX | 53.17 | N/A | N/A |
| Fidelity Advisor Biotechnology Z | |||
| TEFQX | 4.84 | N/A | N/A |
| Firsthand Technology Opportunities | |||